Evidence map›Paper›PMID 30547800›Full record

ArticleBMC neurology2018

Using automated electronic medical record data extraction to model ALS survival and progression.

Alex G Karanevich, Luke J Weisbrod, Omar Jawdat, Richard J Barohn, Byron J Gajewski, Jianghua He, Jeffrey M Statland

Open access · goldAbstract read
In one paragraph

Article in BMC neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Alex G KaranevichDepartment of Biostatistics, University of Kansas Medical Center, Kansas City, USA. akaranevich@embstats.com.
Luke J WeisbrodSchool of Medicine, University of Kansas Medical Center, Kansas City, USA.
Omar JawdatDepartment of Neurology, University of Kansas Medical Center, Kansas City, USA.
Richard J BarohnDepartment of Neurology, University of Kansas Medical Center, Kansas City, USA.
Byron J GajewskiDepartment of Biostatistics, University of Kansas Medical Center, Kansas City, USA.
Jianghua HeDepartment of Biostatistics, University of Kansas Medical Center, Kansas City, USA.
Jeffrey M StatlandDepartment of Neurology, University of Kansas Medical Center, Kansas City, USA.
University of Kansas Medical Center · US

Funding

RADx-UP: Improving the Response of Local Urban and Rural Communities to Disparities in Covid-19 TestingUL1TR002366 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mario Castro, JAMES STEVEN LEEDER · 2017 to 2026
$44.3M
Uncovering new genes and disease modifiers for ALS and related disordersU54NS092091 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Michael Benatar · 2014 to 2026
$19.8M
Heartland Institute for Clinical and Translational ResearchUL1TR000001 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2012 to 2015
$13.0M
HEARTLAND INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCHUL1RR033179 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2011 to 2011
$3.2M
NCATS / Clinical Research in ALS and Related Disorders for Therapeutic Development Consortium U54NS092091NCATS NIH HHS UL1 TR000001NCATS NIH HHS UL1 TR002366NCRR and NCATS UL1TR000001 (formerly UL1RR033179)NCRR NIH HHS UL1 RR033179NINDS NIH HHS U54 NS092091
6 · The paper itself

Abstract

backgroundTo assess the feasibility of using automated capture of Electronic Medical Record (EMR) data to build predictive models for amyotrophic lateral sclerosis (ALS) outcomes.

methodsWe used an Informatics for Integrating Biology and the Bedside search discovery tool to identify and extract data from 354 ALS patients from the University of Kansas Medical Center EMR. The completeness and integrity of the data extraction were verified by manual chart review. A linear mixed model was used to model disease progression. Cox proportional hazards models were used to investigate the effects of BMI, gender, and age on survival.

resultsData extracted from the EMR was sufficient to create simple models of disease progression and survival. Several key variables of interest were unavailable without including a manual chart review. The average ALS Functional Rating Scale - Revised (ALSFRS-R) baseline score at first clinical visit was 34.08, and average decline was - 0.64 per month. Median survival was 27 months after first visit. Higher baseline ALSFRS-R score and BMI were associated with improved survival, higher baseline age was associated with decreased survival.

conclusionsThis study serves to show that EMR-captured data can be extracted and used to track outcomes in an ALS clinic setting, potentially important for post-marketing research of new drugs, or as historical controls for future studies. However, as automated EMR-based data extraction becomes more widely used there will be a need to standardize ALS data elements and clinical forms for data capture so data can be pooled across academic centers.

Indexed as

Amyotrophic Lateral SclerosisDisease ProgressionElectronic Health RecordsAdultAgedFemaleHumansLinear ModelsMaleMiddle AgedProportional Hazards ModelsAmyotrophic lateral sclerosisDisease progressionElectronic medical recordMotor neuron disease

Identifiers

PMID30547800
PMCPMC6295028
OpenAlexW2904305949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.